RDHL - RedHill Biopharma gets Nasdaq non-compliance notice

2023-05-16 05:33:39 ET

• RedHill Biopharma ( NASDAQ: RDHL ) received a notice from Nasdaq for not being in compliance with the rule of minimum $15M market value of shares for continued listing on the exchange.
• The Israeli company said it has 180 calendar days, or until Nov. 6, to regain compliance.
• If during the compliance period, the minimum market value of publicly held shares of the company closes at $15M or more for a minimum of 10 consecutive business days, RedHill will regain compliance.
• If the company does not regain compliance before the period ends, it will receive notice that its securities could be delisted.
• The company noted that it may consider applying to transfer its securities to the Nasdaq Capital Market.

For further details see: